Skip to main content
Caplight Logo









Acorai

Acorai

Private
HelsingborgHealthcare & Life Scienceshttps://acorai.com/

Last Round

VC Round

Nov 27, 2024

Total Funding Raised

$6.96M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Acorai is a medical technology company developing a non-invasive device for cardiac and pulmonary pressure sensing to help manage heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

cardiac monitoringheart failure managementnon-invasive diagnosticshemodynamic monitoringmedical devicedigital healthpoint-of-care diagnosticsmedical AIintracardiac pressureclinical decision supporthealth IoTremote patient monitoringRPMmedtechSaaSwearable health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acorai Comparables

Compare Acorai with similar companies based on industry and business-model similarity.

Acorai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sensydia
83%
Cardiosense
83%
CardioStory
83%

Acorai Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 27, 2024
SeedJan 22, 2024
GrantNov 8, 2023

Key People

Founding team and executive leadership

Kasper Bourdette

Co-founder COO

Founding Team

Jakob Gelberg

Chief Technology Officer

Executive Team

Peter Larsson

Interim Group CFO Through Evolvefy AB

Executive Team

Acorai Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 32% MoM, reaching 2.1K.

  • Jan 1, 2026

    Awarded for non-invasive cardiac monitoring platform.

Acorai Filings

Explore SEC and related filing metadata, where available.

Acorai filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Acorai's valuation, stock price, and market status.

Is Acorai a public or private company?

Acorai is a private company.

What is the current stock price of Acorai?

Acorai is a private company with no public stock price. No recent secondary market data is available.

How much is Acorai worth (valuation)?

Valuation information for Acorai is not publicly available.

Can I buy Acorai stock?

Acorai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Acorai's last funding round?

Acorai's most recent funding round was Seed on January 22, 2024.

Who are the main investors in Acorai?

Key investors in Acorai include Golden Angels Investors, European Innovation Council, Life Science Invest, Life Science Invest, CARMA FUND.

Will Acorai IPO soon?

No public IPO plans have been announced for Acorai.

How can I track Acorai secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Acorai's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHelsingborg
Employee Range30
Year Founded2019
Last FundingNov 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?